Robert Babak Faryabi
Affiliations: | 2010-2015 | National Cancer Institute, NIH, Bethesda, Bethesda, MD, United States |
Google:
"Robert Faryabi"Parents
Sign in to add mentor| Andre Nussenzweig | post-doc | 2010-2015 | National Cancer Institute, NIH, Bethesda |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Goldman N, Chandra A, Johnson I, et al. (2023) Intrinsically disordered domain of transcription factor TCF-1 is required for T cell developmental fidelity. Nature Immunology |
| Verma P, Zhou Y, Cao Z, et al. (2021) ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination-deficient cells. Nature Cell Biology |
| Rome KS, Stein SJ, Kurachi M, et al. (2020) Trib1 regulates T cell differentiation during chronic infection by restraining the effector program. The Journal of Experimental Medicine. 217 |
| Fasolino M, Goldman N, Wang W, et al. (2020) Genetic Variation in Type 1 Diabetes Reconfigures the 3D Chromatin Organization of T Cells and Alters Gene Expression. Immunity |
| Taylor DM, Aronow BJ, Tan K, et al. (2019) The Pediatric Cell Atlas: Defining the Growth Phase of Human Development at Single-Cell Resolution. Developmental Cell |
| Petrovic J, Zhou Y, Fasolino M, et al. (2019) Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques. Molecular Cell |
| Li J, Byrne KT, Yan F, et al. (2018) Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity |
| Pajcini KV, Xu L, Shao L, et al. (2017) MAFB enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia. Science Signaling. 10 |
| Ryan RJH, Petrovic J, Rausch DM, et al. (2017) A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas. Cell Reports. 21: 784-797 |
| Rolland DCM, Basrur V, Jeon YK, et al. (2017) Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas. Proceedings of the National Academy of Sciences of the United States of America |